Drug Research
AbbVie to Assume Full Development and Commercial Control of Cystic Fibrosis Research Program
AbbVie ,a research-based global biopharmaceutical company, announced that it will assume full development and commercial responsibility for its collaboration with Galapagos to discover and...
Press Releases
Shionogi Announces FDA Approval of XOFLUZA for the Treatment of Acute, Uncomplicated Influenza
Shionogi & Co., Ltd. announced recently that, after completing a Priority Review, the USA FDA has approved XOFLUZA (baloxavir marboxil) for the treatment of...
Clinical Trials
REGENXBIO Announces Additional Positive Interim Phase I Trial Update for RGX-314
REGENXBIO Inc. a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology...
Press Releases
Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins
Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused company, have entered into a two-year collaborative partnership to...
Press Releases
Enzyme Products from Amano Enzyme Support Regenerative Medicine
Since the advent of iPS cells, there have been high expectations regarding their potential application in the field of regenerative medicine. Some time has...
Drug Research
Arzeda Leverages Scalable Synthetic Biology Resources to Drive Computational Protein Design Platform
Arzeda, the Protein Design Compan, Twist Bioscience Corporation, TeselaGen Biotechnology Inc. and Labcyte Inc. have partnered to build a state-of-the-art DNA assembly platform to...
Articles
DSCSA one-month countdown
From 27 November 2018, the Drug Supply Chain Security Act (DSCSA) will be actively enforced by regulators in the US. Here,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read